Product References
Engineering a High-Affinity PD-1 Peptide for Optimized Immune Cell-Mediated Tumor Therapy.
Cancer research and treatment
Chen Y,Huang H,Liu Y,Wang Z,Wang L,Wang Q,Zhang Y,Wang H
16-9989-82 was used in Cell Culture to optimize a peptide (nABP284) that binds to PD-1 by a computer-based protocol in order to increase its affinity.
Fri Apr 01 00:00:00 UTC 2022
Correlations of the expression of γδ T cells and their co-stimulatory molecules TIGIT, PD-1, ICOS and BTLA with PR and PIBF in the peripheral blood and decidual tissues of women with unexplained recurrent spontaneous abortion.
Clinical and experimental immunology
Liang Q,Tong L,Xiang L,Shen S,Pan C,Liu C,Zhang H
Published figure using CD279 (PD-1) monoclonal antibody (Product # 16-9989-82) in Flow Cytometry
Fri Jan 01 00:00:00 UTC 2021
PD-1 Involvement in Peripheral Blood CD8+ T Lymphocyte Dysfunction in Patients with Acute-on-chronic Liver Failure.
Journal of clinical and translational hepatology
Zhou X,Li Y,Ji Y,Liu T,Zhao N,He J,Yao J
16-9989-82 was used in Flow Cytometry, Functional Assay to explore the role of PD-1 in CD8+ T lymphocyte dysfunction in hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF).
Mon Jun 28 00:00:00 UTC 2021
Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model.
Frontiers in immunology
Lee SWL,Adriani G,Ceccarello E,Pavesi A,Tan AT,Bertoletti A,Kamm RD,Wong SC
16-9989-82 was used in Inhibition Assays to investigate the immunosuppressive potential of monocytes toward hepatitis B virus-specific T cell receptor-redirected T cells and the role of PD-L1/PD-1 signalling.
Mon Jun 24 00:00:00 UTC 2019
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients.
Oncoimmunology
Palermo B,Franzese O,Donna CD,Panetta M,Quintarelli C,Sperduti I,Gualtieri N,Foddai ML,Proietti E,Ferraresi V,Ciliberto G,Nisticò P
16-9989 was used in Flow cytometry/Cell sorting to show that T-cell clones isolated from patients treated with peptide vaccination alone possessed an early/intermediate differentiated phenotype, whereas T cells isolated after DTIC plus vaccination were late-differentiated.
Tue Jan 12 00:00:00 UTC 2021
Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
Neuro-oncology
Hardcastle J,Mills L,Malo CS,Jin F,Kurokawa C,Geekiyanage H,Schroeder M,Sarkaria J,Johnson AJ,Galanis E
16-9989 was used in Functional assays to demonstrate that oncolytic measles virotherapy in combination with anti-programmed cell death protein 1 blockade significantly improves survival outcome in a syngeneic glioblastoma model.
Sat Apr 01 00:00:00 UTC 2017
Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.
Oncoimmunology
Franzese O,Palermo B,Di Donna C,Sperduti I,Ferraresi V,Stabile H,Gismondi A,Santoni A,Nisticò P
16-9989 was used in Functional assays to investigate polyfunctionality of CD8(+) T cells relating to AKT activation.
Sun May 01 00:00:00 UTC 2016
Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.
Oncoimmunology
Franzese O,Palermo B,Di Donna C,Sperduti I,Ferraresi V,Stabile H,Gismondi A,Santoni A,Nisticò P
16-9989 was used in Functional assays to investigate polyfunctionality of CD8(+) T cells relating to AKT activation.
Sun May 01 00:00:00 UTC 2016
Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor.
Oncotarget
Li Q,Quan L,Lyu J,He Z,Wang X,Meng J,Zhao Z,Zhu L,Liu X,Li H
16-9989 was used in an ELISA assay to design several hPD-1 binding peptides.
Tue Oct 04 00:00:00 UTC 2016
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research
Görgün G,Samur MK,Cowens KB,Paula S,Bianchi G,Anderson JE,White RE,Singh A,Ohguchi H,Suzuki R,Kikuchi S,Harada T,Hideshima T,Tai YT,Laubach JP,Raje N,Magrangeas F,Minvielle S,Avet-Loiseau H,Munshi NC,Dorfman DM,Richardson PG,Anderson KC
16-9989 was used in Flow cytometry/Cell sorting to demonstrate that checkpoint signaling plays an important role in providing the tumor-promoting, immune-suppressive microenvironment in multiple myeloma.
Thu Oct 15 00:00:00 UTC 2015
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.
American journal of respiratory and critical care medicine
Braun NA,Celada LJ,Herazo-Maya JD,Abraham S,Shaginurova G,Sevin CM,Grutters J,Culver DA,Dworski R,Sheller J,Massion PP,Polosukhin VV,Johnson JE,Kaminski N,Wilkes DS,Oswald-Richter KA,Drake WP
16-9989 was used in Blocking experiments to determine the effects of PD-1 pathway blockade on sarcoidosis CD4(+) T-cell proliferative capacity, showing that blockade restores proliferative capacity, making it a possible therapeutic target.
Mon Sep 01 00:00:00 UTC 2014
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
Journal of immunology (Baltimore, Md. : 1950)
Jurado JO,Alvarez IB,Pasquinelli V,Martínez GJ,Quiroga MF,Abbate E,Musella RM,Chuluyan HE,García VE
Tue Jul 01 00:00:00 UTC 2008
Expression and function of PDCD1 at the human maternal-fetal interface.
Biology of reproduction
Taglauer ES,Trikhacheva AS,Slusser JG,Petroff MG
Mon Sep 01 00:00:00 UTC 2008
Expression and function of PDCD1 at the human maternal-fetal interface.
Biology of reproduction
Taglauer ES,Trikhacheva AS,Slusser JG,Petroff MG
Mon Sep 01 00:00:00 UTC 2008
FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.
BMC cancer
Ghebeh H,Barhoush E,Tulbah A,Elkum N,Al-Tweigeri T,Dermime S
Sat Feb 23 00:00:00 UTC 2008
FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.
BMC cancer
Ghebeh H,Barhoush E,Tulbah A,Elkum N,Al-Tweigeri T,Dermime S
Sat Feb 23 00:00:00 UTC 2008
Expression of B7-H1 in inflammatory renal tubular epithelial cells.
Nephron. Experimental nephrology
Chen Y,Zhang J,Li J,Zou L,Zhao T,Tang Y,Wu Y
Fri Apr 21 00:00:00 UTC 2006
Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.
Blood
Godfrey WR,Spoden DJ,Ge YG,Baker SR,Liu B,Levine BL,June CH,Blazar BR,Porter SB
Sat Jan 15 00:00:00 UTC 2005
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Nature medicine
Dong H,Strome SE,Salomao DR,Tamura H,Hirano F,Flies DB,Roche PC,Lu J,Zhu G,Tamada K,Lennon VA,Celis E,Chen L
Thu Aug 01 00:00:00 UTC 2002